The roles of UVB and vitamin D in reducing risk of cancer incidence and mortality: A review of the epidemiology, clinical trials, and mechanisms

[1]  A. Pontecorvi,et al.  Vitamin D and pancreas: The role of sunshine vitamin in the pathogenesis of diabetes mellitus and pancreatic cancer , 2017, Critical reviews in food science and nutrition.

[2]  A. Kunnumakkara,et al.  Recent development of targeted approaches for the treatment of breast cancer , 2017, Breast Cancer.

[3]  K. Brokstad,et al.  25-Hydroxy-Vitamin D Concentration Is Not Affected by Severe or Non-Severe Pneumonia, or Inflammation, in Young Children , 2017, Nutrients.

[4]  M. Linet,et al.  Prospective study of ultraviolet radiation exposure and risk of breast cancer in the United States. , 2016, Environmental research.

[5]  A. Gudkov,et al.  p53 and the Carcinogenicity of Chronic Inflammation. , 2016, Cold Spring Harbor perspectives in medicine.

[6]  R. Recker,et al.  Vitamin D3 and calcium supplementation significantly decreases cancer risk in older women , 2016 .

[7]  Ashutosh Kumar Singh,et al.  Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, The Lancet.

[8]  A. Whittemore,et al.  Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study. , 2016, International journal of epidemiology.

[9]  Andrew H. Beck,et al.  Plasma 25-Hydroxyvitamin D and Risk of Breast Cancer in Women Followed over 20 Years. , 2016, Cancer research.

[10]  H. Mutlu,et al.  More sunlight exposure may improve the overall survival in patients with pancreas cancer , 2016 .

[11]  K. Nakayama,et al.  To wake up cancer stem cells, or to let them sleep, that is the question , 2016, Cancer science.

[12]  W. Grant.  Roles of Solar UVB and Vitamin D in Reducing Cancer Risk and Increasing Survival. , 2016, Anticancer research.

[13]  G. Deep,et al.  Oxidative stress and metabolic disorders: Pathogenesis and therapeutic strategies. , 2016, Life sciences.

[14]  D. Albanes,et al.  Circulating 25-Hydroxyvitamin D and Prostate Cancer Survival , 2016, Cancer Epidemiology, Biomarkers & Prevention.

[15]  Jing Zhu,et al.  1,25(OH)2D3 attenuates TGF-β1/β2-induced increased migration and invasion via inhibiting epithelial-mesenchymal transition in colon cancer cells. , 2015, Biochemical and biophysical research communications.

[16]  Ling Wang,et al.  Circulating 25-hydroxyvitamin D and risk of lung cancer: a dose–response meta-analysis , 2015, Cancer Causes & Control.

[17]  R. Scragg,et al.  Is outdoor recreational activity an independent predictor of cardiovascular disease mortality - NHANES III? , 2015, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[18]  A. Benammar-Elgaaied,et al.  The immune microenvironment of the colorectal tumor: Involvement of immunity genes and microRNAs belonging to the TH17 pathway. , 2015, Biochimica et biophysica acta.

[19]  A. El-Shemi,et al.  Vitamin D3 enhances the tumouricidal effects of 5-Fluorouracil through multipathway mechanisms in azoxymethane rat model of colon cancer , 2015, Journal of experimental & clinical cancer research : CR.

[20]  B. Jenkins,et al.  Inflammatory and non-inflammatory roles for Toll-like receptors in gastrointestinal cancer. , 2015, Current pharmaceutical design.

[21]  Liqun Zhang,et al.  Vitamin D and Lung Cancer Risk: A Comprehensive Review and Meta-Analysis , 2015, Cellular Physiology and Biochemistry.

[22]  M. Diehn,et al.  Inhibition of Mouse Breast Tumor-Initiating Cells by Calcitriol and Dietary Vitamin D , 2015, Molecular Cancer Therapeutics.

[23]  S. Diaz-Cano.  Pathological Bases for a Robust Application of Cancer Molecular Classification , 2015, International journal of molecular sciences.

[24]  H. Maehr,et al.  Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer , 2015, The Journal of Steroid Biochemistry and Molecular Biology.

[25]  S. Mohr,et al.  Could vitamin D sufficiency improve the survival of colorectal cancer patients? , 2015, The Journal of Steroid Biochemistry and Molecular Biology.

[26]  G. Kibria,et al.  Cancer stem cells: targeting the roots of cancer, seeds of metastasis, and sources of therapy resistance. , 2015, Cancer research.

[27]  W. Grant.  25-hydroxyvitamin D and breast cancer, colorectal cancer, and colorectal adenomas: case-control versus nested case-control studies. , 2015, Anticancer research.

[28]  Jessica L. Kelts,et al.  Vitamin D effect on growth and vitamin D metabolizing enzymes in triple-negative breast cancer. , 2015, Anticancer research.

[29]  S. Glück,et al.  Improved clinical outcomes associated with vitamin D supplementation during adjuvant chemotherapy in patients with HER2+ nonmetastatic breast cancer. , 2015, Clinical breast cancer.

[30]  F. D. de Gruijl,et al.  UV exposure inhibits intestinal tumor growth and progression to malignancy in intestine‐specific Apc mutant mice kept on low vitamin D diet , 2015, International journal of cancer.

[31]  J. Laterra,et al.  Cancer Stem Cells: Dynamic Entities in an Ever-Evolving Paradigm , 2014, Biology and medicine.

[32]  E. Kallay,et al.  The vitamin D system is deregulated in pancreatic diseases , 2014, The Journal of Steroid Biochemistry and Molecular Biology.

[33]  A. Tenesa,et al.  Plasma vitamin D concentration influences survival outcome after a diagnosis of colorectal cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  W. Swietnicki,et al.  Vitamin D analogs combined with 5-fluorouracil in human HT-29 colon cancer treatment , 2014, Oncology reports.

[35]  Zhaofen Lin,et al.  Positive association between circulating 25-hydroxyvitamin D levels and prostate cancer risk: new findings from an updated meta-analysis , 2014, Journal of Cancer Research and Clinical Oncology.

[36]  H. DeLuca.  History of the discovery of vitamin D and its active metabolites. , 2014, BoneKEy reports.

[37]  B. Rosner,et al.  Surrogates of Long-Term Vitamin D Exposure and Ovarian Cancer Risk in Two Prospective Cohort Studies , 2013, Cancers.

[38]  H. Juang,et al.  MART-10, a novel vitamin D analog, inhibits head and neck squamous carcinoma cells growth through cell cycle arrest at G0/G1 with upregulation of p21 and p27 and downregulation of telomerase , 2013, The Journal of Steroid Biochemistry and Molecular Biology.

[39]  W. Grant,et al.  Molecular Link between Vitamin D and Cancer Prevention , 2013, Nutrients.

[40]  F. Ruemmele,et al.  Transforming growth factor and intestinal inflammation: the role of nutrition. , 2013, Nestle Nutrition Institute workshop series.

[41]  A. Kutner,et al.  Vitamin D analogs enhance the anticancer activity of 5-fluorouracil in an in vivo mouse colon cancer model , 2013, BMC Cancer.

[42]  A. Kutner,et al.  Combined colonic cancer treatment with vitamin D analogs and irinotecan or oxaliplatin. , 2013, Anticancer research.

[43]  E. Kallay,et al.  Role of calcium, vitamin D, and the extrarenal vitamin D hydroxylases in carcinogenesis. , 2012, Anti-cancer agents in medicinal chemistry.

[44]  H. Juang,et al.  MART-10, a New Generation of Vitamin D Analog, Is More Potent than 1α,25-Dihydroxyvitamin D3 in Inhibiting Cell Proliferation and Inducing Apoptosis in ER+ MCF-7 Breast Cancer Cells , 2012, Evidence-based complementary and alternative medicine : eCAM.

[45]  P. Kruk,et al.  1,25-Dihydroxyvitamin D3 Suppresses Telomerase Expression and Human Cancer Growth through MicroRNA-498* , 2012, The Journal of Biological Chemistry.

[46]  R. Lucas,et al.  Association between Ambient Ultraviolet Radiation and Risk of Epithelial Ovarian Cancer , 2012, Cancer Prevention Research.

[47]  C. Abnet,et al.  Prospective study of ultraviolet radiation exposure and risk of cancer in the United States , 2012, International journal of cancer.

[48]  F. Hamdy,et al.  Associations of circulating 25‐hydroxyvitamin D with prostate cancer diagnosis, stage and grade , 2012, International journal of cancer.

[49]  I. Romieu,et al.  Serum 25-hydroxyvitamin D and risk of breast cancer: results of a large population-based case–control study in Mexican women , 2012, Cancer Causes & Control.

[50]  JoAnn E Manson,et al.  The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. , 2012, Endocrine reviews.

[51]  P. Hershberger,et al.  CYP24 inhibition preserves 1α,25-dihydroxyvitamin D3 anti-proliferative signaling in lung cancer cells , 2012, Molecular and Cellular Endocrinology.

[52]  E. Garrett-Mayer,et al.  Vitamin D3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance. , 2012, The Journal of clinical endocrinology and metabolism.

[53]  K. Jensen,et al.  Dietary vitamin D₃ and 1,25-dihydroxyvitamin D₃ (calcitriol) exhibit equivalent anticancer activity in mouse xenograft models of breast and prostate cancer. , 2012, Endocrinology.

[54]  M. Lucia,et al.  Effect of dietary vitamin D and calcium on the growth of androgen-insensitive human prostate tumor in a murine model. , 2012, Anticancer research.

[55]  S. Tretli,et al.  Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study , 2011, Cancer Causes & Control.

[56]  J. Manson,et al.  Plasma 25-Hydroxyvitamin D and Risk of Pancreatic Cancer , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[57]  Yanlei Ma,et al.  Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[58]  I. Reid,et al.  Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set. , 2011, The American journal of clinical nutrition.

[59]  C. Morrison,et al.  Differential vitamin D 24-hydroxylase/CYP24A1 gene promoter methylation in endothelium from benign and malignant human prostate , 2011, Epigenetics.

[60]  H. Brenner,et al.  Meta-analysis: Serum vitamin D and colorectal adenoma risk. , 2011, Preventive medicine.

[61]  W. Grant.  Effect of interval between serum draw and follow-up period on relative risk of cancer incidence with respect to 25-hydroxyvitamin D level; implications for meta-analyses and setting vitamin D guidelines , 2011, Dermato-endocrinology.

[62]  S. Carreau,et al.  Regulation of aromatase expression by 1α,25(OH)2 vitamin D3 in rat testicular cells. , 2011, Reproduction, fertility, and development.

[63]  G. Byrnes,et al.  Meta‐analysis of observational studies of serum 25‐hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma , 2011, International journal of cancer.

[64]  S. Edge,et al.  Pretreatment Serum Concentrations of 25-Hydroxyvitamin D and Breast Cancer Prognostic Characteristics: A Case-Control and a Case-Series Study , 2011, PloS one.

[65]  Anil V. Parwani,et al.  Nuclear vitamin D receptor expression is associated with improved survival in non-small cell lung cancer , 2011, The Journal of Steroid Biochemistry and Molecular Biology.

[66]  Dean E Brenner,et al.  CYP24A1 Is an Independent Prognostic Marker of Survival in Patients with Lung Adenocarcinoma , 2010, Clinical Cancer Research.

[67]  D. Feldman,et al.  Vitamin D and breast cancer: Inhibition of estrogen synthesis and signaling , 2010, The Journal of Steroid Biochemistry and Molecular Biology.

[68]  W. Hrushesky,et al.  Global breast cancer seasonality , 2010, Breast Cancer Research and Treatment.

[69]  Zhentao Zhang,et al.  1,25 dihydroxyvitamin D-mediated orchestration of anticancer, transcript-level effects in the immortalized, non-transformed prostate epithelial cell line, RWPE1 , 2010, BMC Genomics.

[70]  Jining Wang,et al.  Tissue-selective regulation of aromatase expression by calcitriol: implications for breast cancer therapy. , 2009, Endocrinology.

[71]  L. Augenlicht,et al.  Macrophage-derived IL-1β stimulates Wnt signaling and growth of colon cancer cells; a crosstalk interrupted by vitamin D3 , 2009, Oncogene.

[72]  N. Weigel,et al.  1Alpha,25-dihydroxyvitamin D3 reduces c-Myc expression, inhibiting proliferation and causing G1 accumulation in C4-2 prostate cancer cells. , 2009, Endocrinology.

[73]  Bryan M. Gillard,et al.  Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis in vivo. , 2009, Cancer research.

[74]  Ying Zhao,et al.  Vitamin D3 Induces Autophagy of Human Myeloid Leukemia Cells* , 2008, Journal of Biological Chemistry.

[75]  P. Hershberger,et al.  1α,25-Dihydroxyvitamin D3 potentiates cisplatin antitumor activity by p73 induction in a squamous cell carcinoma model , 2008, Molecular Cancer Therapeutics.

[76]  B. Bao,et al.  Protective role of 1α, 25‐dihydroxyvitamin D3 against oxidative stress in nonmalignant human prostate epithelial cells , 2008, International journal of cancer.

[77]  C. Mathieu,et al.  Vitamin D and human health: lessons from vitamin D receptor null mice. , 2008, Endocrine reviews.

[78]  D. Trump,et al.  Vitamin D signalling pathways in cancer: potential for anticancer therapeutics , 2007, Nature Reviews Cancer.

[79]  M. Fraga,et al.  The Wnt antagonist DICKKOPF-1 gene is induced by 1alpha,25-dihydroxyvitamin D3 associated to the differentiation of human colon cancer cells. , 2007, Carcinogenesis.

[80]  E. White,et al.  Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. , 2007, Genes & development.

[81]  R. Recker,et al.  Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. , 2007, The American journal of clinical nutrition.

[82]  E. White,et al.  Autophagy suppresses tumor progression by limiting chromosomal instability. , 2007, Genes & development.

[83]  Riccardo Fodde,et al.  Wnt/β-catenin signaling in cancer stemness and malignant behavior , 2007 .

[84]  D. Dang,et al.  1α,25-dihydroxyvitamin D3 (Calcitriol) inhibits hypoxia-inducible factor-1/vascular endothelial growth factor pathway in human cancer cells , 2007, Molecular Cancer Therapeutics.

[85]  S. Rakoff-Nahoum,et al.  Why Cancer and Inflammation? , 2006, The Yale journal of biology and medicine.

[86]  W. Willett,et al.  Cancer Incidence and Mortality and Vitamin D in Black and White Male Health Professionals , 2006, Cancer Epidemiology Biomarkers & Prevention.

[87]  G. Carmeliet,et al.  Vitamin D and cancer , 2006, The Journal of Steroid Biochemistry and Molecular Biology.

[88]  M. Nichols,et al.  CYP24, the enzyme that catabolizes the antiproliferative agent vitamin D, is increased in lung cancer , 2006, International journal of cancer.

[89]  Jorge Yao,et al.  1 a , 25-dihydroxyvitamin D 3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis , 2006 .

[90]  W. Birchmeier,et al.  Aberrant Wnt/beta-catenin signaling can induce chromosomal instability in colon cancer. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[91]  W. Grant,et al.  The association of solar ultraviolet B (UVB) with reducing risk of cancer: multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. , 2006, Anticancer research.

[92]  A. Roberts,et al.  TGF-β and Vitamin D3 Utilize Distinct Pathways to Suppress IL-12 Production and Modulate Rapid Differentiation of Human Monocytes into CD83+ Dendritic Cells , 2005, The Journal of Immunology.

[93]  E. Blackburn,et al.  Telomeres and telomerase: their mechanisms of action and the effects of altering their functions , 2005, FEBS letters.

[94]  S. Nicosia,et al.  Induction of Ovarian Cancer Cell Apoptosis by 1,25-Dihydroxyvitamin D3 through the Down-regulation of Telomerase* , 2004, Journal of Biological Chemistry.

[95]  Hans Clevers,et al.  At the Crossroads of Inflammation and Cancer , 2004, Cell.

[96]  Takaaki Masuda,et al.  Clinical significance of the overexpression of the candidate oncogene CYP24 in esophageal cancer. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[97]  J. Testa,et al.  Tumor suppressor genes and the two‐hit model of recessive oncogenesis: Celebrating Alfred Knudson's 80th birthday , 2003, Genes, chromosomes & cancer.

[98]  S. Nicosia,et al.  G2/M Arrest by 1,25-Dihydroxyvitamin D3 in Ovarian Cancer Cells Mediated through the Induction of GADD45 via an Exonic Enhancer* , 2003, Journal of Biological Chemistry.

[99]  S. Kyo,et al.  Combination treatment with 1alpha,25-dihydroxyvitamin D3 and 9-cis-retinoic acid directly inhibits human telomerase reverse transcriptase transcription in prostate cancer cells. , 2003, Molecular cancer therapeutics.

[100]  N. Raghavachari,et al.  Vitamin D Growth Inhibition of Breast Cancer Cells: Gene Expression Patterns Assessed by cDNA Microarray , 2003, Breast Cancer Research and Treatment.

[101]  P. Dhawan,et al.  New insights into the mechanisms of vitamin D action , 2003, Journal of cellular biochemistry.

[102]  L. Coussens,et al.  Inflammation and cancer , 2002, Nature.

[103]  M. Bissonnette,et al.  Transforming growth factor-β1 signaling contributes to Caco-2 cell growth inhibition induced by 1,25(OH)2D3 , 2002 .

[104]  David E. Misek,et al.  Gene-expression profiles predict survival of patients with lung adenocarcinoma , 2002, Nature Medicine.

[105]  I. Tomlinson,et al.  Loss of heterozygosity analysis: Practically and conceptually flawed? , 2002, Genes, chromosomes & cancer.

[106]  J. Schellens,et al.  Cisplatin potentiates 1,25-dihydroxyvitamin D3-induced apoptosis in association with increased mitogen-activated protein kinase kinase kinase 1 (MEKK-1) expression. , 2002, Molecular cancer therapeutics.

[107]  T. Brabletz,et al.  β-Catenin and the morphogenesis of colorectal cancer , 2002, Virchows Archiv.

[108]  W. Grant.  An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet‐B radiation , 2002, Cancer.

[109]  M. Zemel,et al.  1α,25‐Dihydroxyvitamin D3 modulates human adipocyte metabolism via nongenomic action , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[110]  T. Mcguire,et al.  Vitamin D(3)-induced apoptosis of murine squamous cell carcinoma cells. Selective induction of caspase-dependent MEK cleavage and up-regulation of MEKK-1. , 2001, The Journal of biological chemistry.

[111]  J. Eisman,et al.  Cross-talk between 1,25-Dihydroxyvitamin D3 and Transforming Growth Factor-β Signaling Requires Binding of VDR and Smad3 Proteins to Their Cognate DNA Recognition Elements* , 2001, The Journal of Biological Chemistry.

[112]  P. Hershberger,et al.  Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[113]  N. Bundred,et al.  1α,25-Dihydroxyvitamin D3 Inhibits Angiogenesis In Vitro and In Vivo , 2000 .

[114]  D. Feldman,et al.  1α,25-Dihydroxyvitamin D3 Down-Regulates Estrogen Receptor Abundance and Suppresses Estrogen Actions in MCF-7 Human Breast Cancer Cells , 2000 .

[115]  W. Kuo,et al.  Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene , 2000, Nature Genetics.

[116]  C. Paraskeva,et al.  Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. , 2000, Cancer research.

[117]  P. Tuohimaa,et al.  Androgen receptor and vitamin D receptor in human ovarian cancer: Growth stimulation and inhibition by ligands , 2000, International journal of cancer.

[118]  H. Koeffler,et al.  5,6-trans-16-ene-vitamin D3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells. , 1999, Cancer research.

[119]  K. Miyazono,et al.  Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators. , 1999, Science.

[120]  R. Bouillon,et al.  Action of 1,25(OH)2D3 on the cell cycle genes, cyclin D1, p21 and p27 in MCF-7 cells , 1998, Molecular and Cellular Endocrinology.

[121]  M. Haussler,et al.  The Nuclear Vitamin D Receptor: Biological and Molecular Regulatory Properties Revealed , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[122]  K. Burnstein,et al.  Antiproliferative Effect of 1α,25-Dihydroxyvitamin D3 in Human Prostate Cancer Cell Line LNCaP Involves Reduction of Cyclin-Dependent Kinase 2 Activity and Persistent G1 Accumulation. , 1998, Endocrinology.

[123]  J. Shay,et al.  A survey of telomerase activity in human cancer. , 1997, European journal of cancer.

[124]  N. Weigel,et al.  1,25-dihydroxyvitamin D3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1. , 1997, Endocrinology.

[125]  C. Chaumontet,et al.  Calcitriol and lexicalcitol (KH1060) inhibit the growth of human breast adenocarcinoma cells by enhancing transforming growth factor-beta production. , 1996, Biochemical pharmacology.

[126]  F. Dilworth,et al.  Different Mechanisms of Hydroxylation Site Selection by Liver and Kidney Cytochrome P450 Species (CYP27 and CYP24) Involved in Vitamin D Metabolism (*) , 1995, The Journal of Biological Chemistry.

[127]  D. Baran,et al.  Rapid Actions of 1α-25-Dihydroxyvitamin D3 Physiologic Role , 1994 .

[128]  G. Jones,et al.  Transfected human liver cytochrome P-450 hydroxylates vitamin D analogs at different side-chain positions. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[129]  C. Garland,et al.  SERUM 25-HYDROXYVITAMIN D AND COLON CANCER: EIGHT-YEAR PROSPECTIVE STUDY , 1989, The Lancet.

[130]  E. Barrett-Connor,et al.  DIETARY VITAMIN D AND CALCIUM AND RISK OF COLORECTAL CANCER: A 19-YEAR PROSPECTIVE STUDY IN MEN , 1985, The Lancet.

[131]  R. Anderson,et al.  Photosynthesis of previtamin D3 in human skin and the physiologic consequences. , 1980, Science.

[132]  C. Garland,et al.  Do sunlight and vitamin D reduce the likelihood of colon cancer? , 1980, International journal of epidemiology.

[133]  J. Frommer,et al.  Isolation and identification of previtamin D3 from the skin of rats exposed to ultraviolet irradiation. , 1979, Biochemistry.

[134]  C. King,et al.  The paths to the discovery of vitamins A and D. , 1967, The Journal of nutrition.

[135]  A. Beckett,et al.  AKUFO AND IBARAPA. , 1965, Lancet.

[136]  W. Grant.  Re: Prospective study of ultraviolet radiation exposure and risk of breast cancer in the United States. , 2017, Environmental research.

[137]  D. Trump,et al.  Mechanistic Insights of Vitamin D Anticancer Effects. , 2016, Vitamins and hormones.

[138]  J. Malm,et al.  Vitamin D, PTH, and calcium and tumor aggressiveness in prostate cancer: a prospective nested case–control study , 2015, Cancer Causes & Control.

[139]  B. Guleng,et al.  Immunopathogenesis of Colitis-Associated Cancer in an Animal Model. , 2015, Critical reviews in eukaryotic gene expression.

[140]  M. Karin,et al.  Tumor-Elicited Inflammation and Colorectal Cancer. , 2015, Advances in cancer research.

[141]  Somchai Thanasitthichai,et al.  Association of Vitamin D Level with Clinicopathological Features in Breast Cancer. , 2015, Asian Pacific journal of cancer prevention : APJCP.

[142]  R. Heaney.  Guidelines for optimizing design and analysis of clinical studies of nutrient effects. , 2014, Nutrition reviews.

[143]  Jacques Ferlay,et al.  GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012 , 2013 .

[144]  C. Mathers,et al.  GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer , 2013 .

[145]  N. Weigel,et al.  1α,25‐dihydroxyvitamin D3 inhibits C4‐2 prostate cancer cell growth via a retinoblastoma protein (Rb)‐independent G1 arrest , 2011, The Prostate.

[146]  B. Terracini.  [International Agency for Research on Cancer Monographs (IARC)]. , 2008, Giornale italiano di medicina del lavoro ed ergonomia.

[147]  D. Leibfritz,et al.  Free radicals and antioxidants in normal physiological functions and human disease. , 2007, The international journal of biochemistry & cell biology.

[148]  Xiaoan Ruan,et al.  Expression of VDR and CYP24A1 mRNA in human tumors , 2005, Cancer Chemotherapy and Pharmacology.

[149]  M. Uskoković,et al.  Combined effect of vitamin D3 analogs and paclitaxel on the growth of MCF-7 breast cancer cells in vivo , 2004, Breast Cancer Research and Treatment.

[150]  T. McDonnell,et al.  Calcitriol-Induced Apoptosis in LNCaP Cells Is Blocked By Overexpression of Bcl-21. , 2000, Endocrinology.

[151]  H. Cross,et al.  Mechanism of antimitogenic action of vitamin D in human colon carcinoma cells: relevance for suppression of epidermal growth factor-stimulated cell growth. , 1999, Oncology research.

[152]  J. Shay,et al.  Telomerase assays in the diagnosis and prognosis of cancer. , 1997, Ciba Foundation symposium.